Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADK | P55263 | 3/20 | 0.66 |
| ▸ | METTL3 | Q86U44 | 1/20 | 0.55 |
| ▸ | PRMT5 | O14744 | 3/20 | 0.53 |
| ▸ | WDR77 | Q9BQA1 | 3/20 | 0.53 |
| ▸ | DPP4 | P27487 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.52 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.52 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.52 |
| ▸ | GAPDH | P04406 | 1/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.52 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.52 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.52 |
| ▸ | STAT6 | P42226 | 1/20 | 0.52 |
| ▸ | PI4KA | P42356 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14609525 | 1.00 | ADK (0.66) | ADKMETTL3PRMT5WDR77DPP4 | |
| Tubercidin SCHEMBL8259 | 0.89 | ADK (0.82) | ADKDPP4MEN1SLC28A1MAP3K7 | |
| Tubercidin SCHEMBL1652797 | 0.89 | ADK (0.82) | ADKDPP4MEN1SLC28A1MAP3K7 | |
| Tubercidin SCHEMBL1739818 | 0.89 | ADK (0.82) | ADKDPP4MEN1SLC28A1MAP3K7 | |
| Tubercidin SCHEMBL23982115 | 0.89 | ADK (0.82) | ADKDPP4MEN1SLC28A1MAP3K7 | |
| Tubercidin SCHEMBL23982350 | 0.89 | ADK (0.82) | ADKDPP4MEN1SLC28A1MAP3K7 | |
| Tubercidin SCHEMBL20419149 | 0.89 | ADK (0.82) | ADKDPP4MEN1SLC28A1MAP3K7 | |
| Tubercidin SCHEMBL23351430 | 0.89 | ADK (0.82) | ADKDPP4MEN1SLC28A1MAP3K7 | |
| Tubercidin SCHEMBL20938187 | 0.89 | ADK (0.82) | ADKDPP4MEN1SLC28A1MAP3K7 | |
| Tubercidin SCHEMBL11239877 | 0.89 | ADK (0.82) | ADKDPP4MEN1SLC28A1MAP3K7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7902202-B2 | Compounds and pharmaceutical compositions for the treatment of viral infections | IDENIX PHARMACEUTICALS, INC. (US) | 2011-03-08 | — | — | US | disclosed |
| US-20090169504-A1 | Compounds and Pharmaceutical compositions for the treatment of Viral infections | IDENIX PHARMACEUTICALS, INC | 2009-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090169504-A1 | Compounds and Pharmaceutical compositions for the treatment of Viral infections | HAVCR2, PYGL, GYS2 | ADK 1032/4885METTL3 3743/4885PRMT5 3572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.